output stringlengths 5 24.3k | instruction stringlengths 33 308 | system stringclasses 1 value |
|---|---|---|
1. Antidepressive Agents [adverse effects, *therapeutic use]; 2. Bias; 3. Citalopram [therapeutic use]; 4. Depressive Disorder, Major [*drug therapy, psychology]; 5. Desvenlafaxine Succinate [therapeutic use]; 6. Duloxetine Hydrochloride [therapeutic use]; 7. Fluoxetine [therapeutic use]; 8. Mirtazapine [therapeutic use]; 9. Network Meta-Analysis; 10. Paroxetine [therapeutic use]; 11. Sertraline [therapeutic use]; 12. Suicidal Ideation; 13. Venlafaxine Hydrochloride [therapeutic use]; 14. Vilazodone Hydrochloride [therapeutic use]; 15. Vortioxetine [therapeutic use]; | Provide MESH terms for the study
New generation antidepressants for depression in children and adolescents: a network meta‐analysis | You are a research assistant. Based on the question please provide appropriate answers |
1. Africa [epidemiology]; 2. Culicidae; 3. Drug Combinations; 4. Feeding Behavior; 5. Insecticide Resistance [*drug effects]; 6. *Insecticide-Treated Bednets; 7. Malaria [epidemiology, *prevention & control]; 8. Mortality; 9. Mosquito Control [*methods]; 10. *Pesticide Synergists; 11. *Piperonyl Butoxide; 12. *Pyrethrins; 13. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Piperonyl butoxide (PBO) combined with pyrethroids in insecticide‐treated nets to prevent malaria in Africa | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Cognitive Behavioral Therapy [*methods]; 3. *Internet-Based Intervention; 4. Randomized Controlled Trials as Topic; 5. Stress Disorders, Post-Traumatic [*therapy]; | Provide MESH terms for the study
Internet‐based cognitive and behavioural therapies for post‐traumatic stress disorder (PTSD) in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Chlorpromazine [therapeutic use]; 3. Clonidine [therapeutic use]; 4. Diazepam [therapeutic use]; 5. Hypnotics and Sedatives [*therapeutic use]; 6. Narcotics [therapeutic use]; 7. Neonatal Abstinence Syndrome [*drug therapy]; 8. Opioid-Related Disorders [*drug therapy]; 9. Phenobarbital [therapeutic use]; 10. Randomized Controlled Trials as Topic; 11. Treatment Outcome; | Provide MESH terms for the study
Sedatives for opioid withdrawal in newborn infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [adverse effects, *therapeutic use]; 2. Bias; 3. Cause of Death; 4. Neonatal Sepsis [*drug therapy]; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Antibiotic regimens for early‐onset neonatal sepsis | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Anti-Asthmatic Agents [therapeutic use]; 3. Asthma [*complications, drug therapy]; 4. Cisapride [therapeutic use]; 5. Disease Progression; 6. Forced Expiratory Volume [drug effects]; 7. Gastroesophageal Reflux [complications, *drug therapy, *surgery]; 8. Histamine Antagonists [therapeutic use]; 9. Peak Expiratory Flow Rate; 10. Placebos [therapeutic use]; 11. Proton Pump Inhibitors; 12. Quality of Life; 13. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Pharmacological and surgical interventions for the treatment of gastro‐oesophageal reflux in adults and children with asthma | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Dental Atraumatic Restorative Treatment [*instrumentation]; 3. Randomized Controlled Trials as Topic; 4. *Rubber Dams; 5. Treatment Outcome; | Provide MESH terms for the study
Rubber dam isolation for restorative treatment in dental patients | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. *Catheters; 3. *Infant, Premature; 4. *Intubation, Intratracheal; 5. Randomized Controlled Trials as Topic; 6. Respiratory Distress Syndrome, Newborn [etiology, *therapy]; 7. Risk; 8. Surface-Active Agents [*administration & dosage]; | Provide MESH terms for the study
Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Topical; 2. Bacterial Infections [mortality, *prevention & control]; 3. Bias; 4. Cross Infection [mortality, *prevention & control]; 5. Dermatitis [*prevention & control]; 6. Emollients [*therapeutic use]; 7. Infant, Extremely Premature; 8. Infant, Premature; 9. Infant, Premature, Diseases [*prevention & control]; 10. Mycoses [mortality, *prevention & control]; 11. Ointments [therapeutic use]; 12. Randomized Controlled Trials as Topic; 13. Skin Care; | Provide MESH terms for the study
Topical emollient for preventing infection in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Controlled Before-After Studies; 3. *Developing Countries; 4. Interrupted Time Series Analysis; 5. Non-Randomized Controlled Trials as Topic; 6. Quality Improvement [*economics, standards]; 7. Quality of Health Care [economics, standards]; 8. *Reimbursement, Incentive; | Provide MESH terms for the study
Paying for performance to improve the delivery of health interventions in low‐ and middle‐income countries | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticonvulsants [adverse effects, *therapeutic use]; 2. Bias; 3. Placebos [therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. Recurrence; 6. Remission Induction; 7. Risk; 8. Secondary Prevention; 9. Seizures [complications, *drug therapy, mortality]; 10. Time Factors; 11. *Time-to-Treatment; 12. Watchful Waiting; | Provide MESH terms for the study
Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [*therapeutic use]; 2. Bias; 3. Microbial Sensitivity Tests [*methods]; 4. Odds Ratio; 5. Randomized Controlled Trials as Topic; 6. Sepsis [*drug therapy, microbiology, mortality]; 7. Time-to-Treatment; | Provide MESH terms for the study
Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection | You are a research assistant. Based on the question please provide appropriate answers |
1. Abdominal Pain [drug therapy]; 2. Cystic Fibrosis [*complications, drug therapy]; 3. Dietary Fats [pharmacokinetics]; 4. Gastric Acid [*metabolism]; 5. Gastrointestinal Agents [therapeutic use]; 6. Histamine H2 Antagonists [*therapeutic use]; 7. Intestinal Absorption [drug effects]; 8. Pancreas [enzymology]; 9. Proton Pump Inhibitors [*therapeutic use]; 10. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Drug therapies for reducing gastric acidity in people with cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Chronic Disease; 3. Cough [*physiopathology]; 4. Disease Progression; 5. Hospitalization [*statistics & numerical data]; 6. Insufflation [methods]; 7. Mucociliary Clearance [*physiology]; 8. Neuromuscular Diseases [*complications]; 9. Patient Satisfaction; 10. Quality of Life; 11. Respiration; 12. Respiration Disorders [etiology]; | Provide MESH terms for the study
Cough augmentation techniques for people with chronic neuromuscular disorders | You are a research assistant. Based on the question please provide appropriate answers |
1. Antidepressive Agents [adverse effects, *therapeutic use]; 2. Bias; 3. Cognitive Behavioral Therapy; 4. Depression [*drug therapy, etiology]; 5. Epilepsy [chemically induced, *drug therapy, psychology]; 6. Non-Randomized Controlled Trials as Topic; 7. Prospective Studies; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; 10. Selective Serotonin Reuptake Inhibitors [adverse effects, therapeutic use]; | Provide MESH terms for the study
Antidepressants for people with epilepsy and depression | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Anti-Asthmatic Agents [administration & dosage, *adverse effects]; 3. Asthma [*drug therapy, mortality]; 4. Beclomethasone [administration & dosage, adverse effects]; 5. Bronchodilator Agents [administration & dosage, adverse effects]; 6. Budesonide [administration & dosage, adverse effects]; 7. Chronic Disease; 8. Drug Therapy, Combination [adverse effects]; 9. Fluticasone [administration & dosage, adverse effects]; 10. Formoterol Fumarate [*administration & dosage, adverse effects]; 11. Glucocorticoids [administration & dosage, *adverse effects]; 12. Mometasone Furoate [administration & dosage, adverse effects]; 13. Randomized Controlled Trials as Topic; 14. Salmeterol Xinafoate [*administration & dosage, adverse effects]; | Provide MESH terms for the study
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events | You are a research assistant. Based on the question please provide appropriate answers |
1. Age of Onset; 2. Anticonvulsants [administration & dosage, adverse effects]; 3. Cannabidiol [administration & dosage, adverse effects]; 4. Cinnamates [administration & dosage, adverse effects]; 5. Clobazam [administration & dosage]; 6. Electroencephalography; 7. Felbamate [administration & dosage]; 8. Lamotrigine [administration & dosage]; 9. Lennox Gastaut Syndrome [*drug therapy]; 10. Placebos [therapeutic use]; 11. Randomized Controlled Trials as Topic; 12. Topiramate [administration & dosage]; 13. Triazoles [administration & dosage]; 14. Wakefulness [physiology]; | Provide MESH terms for the study
Anti‐seizure medications for Lennox‐Gastaut syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Circumcision, Male [adverse effects, *instrumentation, *methods]; 3. Operative Time; 4. Pain, Postoperative [epidemiology]; 5. Patient Preference [statistics & numerical data]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Circumcision devices versus standard surgical techniques in adolescent and adult male circumcisions | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Bronchopulmonary Dysplasia [*epidemiology]; 3. Confidence Intervals; 4. Incidence; 5. Infant, Premature; 6. Oxygen [administration & dosage]; 7. Positive-Pressure Respiration [adverse effects, methods]; 8. Respiration, Artificial [*adverse effects, methods, statistics & numerical data]; 9. Respiratory Distress Syndrome, Newborn [*therapy]; 10. Ventilator-Induced Lung Injury [*mortality, prevention & control]; | Provide MESH terms for the study
Lung recruitment manoeuvres for reducing mortality and respiratory morbidity in mechanically ventilated neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. Cystic Fibrosis [*drug therapy]; 2. Deoxyribonuclease I [adverse effects, *therapeutic use]; 3. Disease Progression; 4. Expectorants [adverse effects, *therapeutic use]; 5. Forced Expiratory Volume; 6. Mannitol [therapeutic use]; 7. Placebos [therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Recombinant Proteins [adverse effects, therapeutic use]; 10. Saline Solution, Hypertonic [therapeutic use]; 11. Vital Capacity; | Provide MESH terms for the study
Dornase alfa for cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Analgesics, Opioid [adverse effects, *therapeutic use]; 2. Bias; 3. Child Development [drug effects]; 4. Fentanyl [adverse effects, therapeutic use]; 5. Heroin [adverse effects, therapeutic use]; 6. Hypnotics and Sedatives [adverse effects, therapeutic use]; 7. Infant Mortality; 8. Infant, Premature; 9. Midazolam [adverse effects, therapeutic use]; 10. Morphine [adverse effects, therapeutic use]; 11. Pain, Procedural [*prevention & control]; 12. Placebos [therapeutic use]; 13. Randomized Controlled Trials as Topic; 14. Remifentanil [adverse effects, therapeutic use]; 15. Respiration, Artificial [*adverse effects, statistics & numerical data]; 16. Sufentanil [adverse effects, therapeutic use]; | Provide MESH terms for the study
Opioids for newborn infants receiving mechanical ventilation | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. *Dietary Supplements; 3. *Infant, Low Birth Weight; 4. Infant, Small for Gestational Age; 5. Perinatal Death [prevention & control]; 6. Pregnancy Outcome; 7. Premature Birth [epidemiology, *prevention & control]; 8. Randomized Controlled Trials as Topic; 9. Stillbirth [epidemiology]; 10. Zinc [*administration & dosage, blood]; | Provide MESH terms for the study
Zinc supplementation for improving pregnancy and infant outcome | You are a research assistant. Based on the question please provide appropriate answers |
1. Bacterial Infections [prevention & control]; 2. Bias; 3. Bronchopulmonary Dysplasia [prevention & control]; 4. Cause of Death; 5. Enteral Nutrition; 6. Enterocolitis, Necrotizing [prevention & control]; 7. Infant Mortality; 8. *Infant, Low Birth Weight [growth & development]; 9. *Infant, Premature [growth & development]; 10. Morbidity; 11. Retinopathy of Prematurity [prevention & control]; 12. Trace Elements [*administration & dosage, deficiency]; 13. Zinc [*administration & dosage, deficiency]; | Provide MESH terms for the study
Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. Enteral Nutrition [adverse effects, *methods]; 2. Enterocolitis, Necrotizing [epidemiology]; 3. Head [growth & development]; 4. *Infant Formula; 5. Infant Nutritional Physiological Phenomena; 6. Infant, Low Birth Weight [*growth & development]; 7. Infant, Premature [*growth & development]; 8. *Milk, Human; 9. Randomized Controlled Trials as Topic; 10. Weight Gain; | Provide MESH terms for the study
High versus standard volume enteral feeds to promote growth in preterm or low birth weight infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Combined Modality Therapy [methods]; 3. Cystic Fibrosis [*therapy]; 4. Deoxyribonuclease I [*administration & dosage]; 5. Drug Administration Schedule; 6. Forced Expiratory Volume; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Recombinant Proteins [administration & dosage]; 10. Respiratory Therapy [*methods]; 11. Time Factors; 12. Vital Capacity; | Provide MESH terms for the study
Timing of dornase alfa inhalation for cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Cognitive Behavioral Therapy [methods]; 3. Confidence Intervals; 4. Depression [therapy]; 5. Dialectical Behavior Therapy [methods]; 6. Family Therapy; 7. *Mentalization; 8. Odds Ratio; 9. Patient Compliance; 10. Psychosocial Intervention [*methods]; 11. Psychotherapy [*methods]; 12. Randomized Controlled Trials as Topic; 13. Recurrence; 14. Secondary Prevention [methods]; 15. Self-Injurious Behavior [prevention & control, psychology, *therapy]; 16. Suicidal Ideation; 17. Treatment Outcome; | Provide MESH terms for the study
Interventions for self‐harm in children and adolescents | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Barotrauma [epidemiology]; 3. Bias; 4. Critical Care [*methods]; 5. Hospital Mortality; 6. Intubation [adverse effects, instrumentation, *methods]; 7. Length of Stay; 8. Masks; 9. Nasal Mucosa [injuries]; 10. Noninvasive Ventilation [methods]; 11. Oxygen Inhalation Therapy [adverse effects, instrumentation, *methods]; 12. Patient Reported Outcome Measures; 13. Pneumonia [epidemiology]; 14. Randomized Controlled Trials as Topic; 15. Respiration, Artificial [adverse effects]; 16. Respiratory Insufficiency [*therapy]; 17. Treatment Failure; | Provide MESH terms for the study
High‐flow nasal cannulae for respiratory support in adult intensive care patients | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Confidence Intervals; 3. Diabetes Mellitus, Type 1 [blood, *drug therapy, mortality]; 4. Hypoglycemia [chemically induced, mortality]; 5. Hypoglycemic Agents [adverse effects, *therapeutic use]; 6. Insulin Detemir [adverse effects, *therapeutic use]; 7. Insulin Glargine [adverse effects, *therapeutic use]; 8. Insulin, Isophane [adverse effects, *therapeutic use]; 9. Insulin, Long-Acting [adverse effects, *therapeutic use]; 10. Myocardial Infarction [chemically induced, mortality]; 11. Quality of Life; 12. Randomized Controlled Trials as Topic; 13. Stroke [chemically induced, mortality]; | Provide MESH terms for the study
(Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [*therapeutic use]; 2. Anti-Infective Agents, Local [therapeutic use]; 3. Bias; 4. Carbuncle [drug therapy]; 5. Furunculosis [*drug therapy]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Interventions for bacterial folliculitis and boils (furuncles and carbuncles) | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [adverse effects, *therapeutic use]; 2. *Antibiotic Prophylaxis [adverse effects]; 3. Bacterial Infections [prevention & control]; 4. Bias; 5. Controlled Clinical Trials as Topic; 6. Dry Socket [prevention & control]; 7. Molar, Third [*surgery]; 8. Pain, Postoperative [prevention & control]; 9. Postoperative Complications [*prevention & control]; 10. Tooth Extraction [*adverse effects]; 11. Tooth, Impacted [*surgery]; | Provide MESH terms for the study
Antibiotics to prevent complications following tooth extractions | You are a research assistant. Based on the question please provide appropriate answers |
1. Caregivers [*education]; 2. Confidence Intervals; 3. Health Facilities [statistics & numerical data]; 4. Patient Education as Topic [*methods]; 5. Pressure Ulcer [epidemiology, *prevention & control]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Risk; 9. Skin Care; 10. Spinal Cord Injuries [complications]; 11. Wound Healing; | Provide MESH terms for the study
Patient and lay carer education for preventing pressure ulceration in at‐risk populations | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Continuous Positive Airway Pressure [statistics & numerical data]; 3. Fluid Therapy [*methods]; 4. Hyperbilirubinemia [epidemiology]; 5. Hypernatremia [epidemiology]; 6. Hypoglycemia [epidemiology]; 7. Infant, Premature; 8. Length of Stay [statistics & numerical data]; 9. Noninvasive Ventilation [statistics & numerical data]; 10. Oxygen Inhalation Therapy [*statistics & numerical data]; 11. Randomized Controlled Trials as Topic; 12. Respiration, Artificial [statistics & numerical data]; 13. Term Birth; 14. Transient Tachypnea of the Newborn [*therapy]; 15. Weight Loss; | Provide MESH terms for the study
Fluid restriction in the management of transient tachypnea of the newborn | You are a research assistant. Based on the question please provide appropriate answers |
1. Autism Spectrum Disorder [*drug therapy]; 2. *Communication; 3. Cycloserine [adverse effects, *therapeutic use]; 4. Indiana; 5. Multicenter Studies as Topic; 6. Ohio; 7. Patient Dropouts [statistics & numerical data]; 8. Placebos [therapeutic use]; 9. Randomized Controlled Trials as Topic; 10. *Social Skills; 11. Stereotyped Behavior [drug effects]; | Provide MESH terms for the study
The effectiveness and adverse effects of D‐cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Topical; 2. Aminoglycosides [administration & dosage]; 3. Amoxicillin-Potassium Clavulanate Combination [administration & dosage]; 4. Anti-Bacterial Agents [*administration & dosage]; 5. Bias; 6. Chronic Disease; 7. Ofloxacin [administration & dosage]; 8. Otitis Media, Suppurative [*drug therapy]; 9. Quinolones [administration & dosage]; 10. Randomized Controlled Trials as Topic; 11. Time Factors; | Provide MESH terms for the study
Topical versus systemic antibiotics for chronic suppurative otitis media | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta-2 Receptor Agonists [*therapeutic use]; 2. Albuterol [*therapeutic use]; 3. Continuous Positive Airway Pressure [statistics & numerical data]; 4. Intermittent Positive-Pressure Ventilation [statistics & numerical data]; 5. Length of Stay [statistics & numerical data]; 6. Nebulizers and Vaporizers; 7. Oxygen Inhalation Therapy [statistics & numerical data]; 8. Randomized Controlled Trials as Topic; 9. Time Factors; 10. Transient Tachypnea of the Newborn [*drug therapy]; | Provide MESH terms for the study
Salbutamol for transient tachypnea of the newborn | You are a research assistant. Based on the question please provide appropriate answers |
1. Amoxicillin [therapeutic use]; 2. Anti-Bacterial Agents [adverse effects]; 3. Ciprofloxacin [therapeutic use]; 4. *Otitis Media, Suppurative [complications]; 5. *Ototoxicity; 6. Pain [drug therapy]; 7. Persistent Infection; | Provide MESH terms for the study
Systemic antibiotics for chronic suppurative otitis media | You are a research assistant. Based on the question please provide appropriate answers |
1. Bacteremia [epidemiology, prevention & control]; 2. Bias; 3. Catheter-Related Infections [epidemiology, prevention & control]; 4. *Central Venous Catheters; 5. Emergency Treatment [adverse effects, instrumentation, *methods, mortality]; 6. Hospitalization [statistics & numerical data]; 7. Observational Studies as Topic [statistics & numerical data]; 8. Peritoneal Dialysis [adverse effects, instrumentation, methods, mortality]; 9. Peritonitis [epidemiology]; 10. Renal Dialysis [adverse effects, instrumentation, *methods, mortality]; 11. Renal Insufficiency, Chronic [mortality, *therapy]; 12. *Time-to-Treatment; | Provide MESH terms for the study
Urgent‐start peritoneal dialysis versus haemodialysis for people with chronic kidney disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta-Antagonists [*adverse effects, therapeutic use]; 2. Chronic Disease; 3. Esophageal and Gastric Varices [*complications]; 4. Gastrointestinal Hemorrhage [etiology, *prevention & control]; 5. Hypertension, Portal [complications]; 6. Liver Diseases [*complications]; 7. Placebos [therapeutic use]; 8. *Portal Vein; 9. Primary Prevention [methods]; 10. Venous Thrombosis [*complications]; | Provide MESH terms for the study
Beta‐blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Bell Palsy [*surgery]; 2. Decompression, Surgical [*methods]; 3. Facial Nerve [*surgery]; 4. Randomized Controlled Trials as Topic; 5. Time-to-Treatment; | Provide MESH terms for the study
Surgical interventions for the early management of Bell's palsy | You are a research assistant. Based on the question please provide appropriate answers |
1. Chronic Disease; 2. Esophageal and Gastric Varices [*complications]; 3. Feasibility Studies; 4. Gastrointestinal Hemorrhage [epidemiology, etiology, *prevention & control]; 5. Ligation [adverse effects, *methods, mortality]; 6. Liver Diseases [*complications]; 7. *Portal Vein; 8. Primary Prevention [methods]; 9. Venous Thrombosis [*complications]; | Provide MESH terms for the study
Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Androgens [blood]; 2. Androstenedione [blood]; 3. Atorvastatin [adverse effects, *pharmacology]; 4. Bias; 5. Dehydroepiandrosterone Sulfate [blood]; 6. Hydroxymethylglutaryl-CoA Reductase Inhibitors [adverse effects, *pharmacology]; 7. Placebos [pharmacology]; 8. Polycystic Ovary Syndrome [*blood, drug therapy]; 9. Randomized Controlled Trials as Topic; 10. Sex Factors; 11. Sex Hormone-Binding Globulin [analysis, drug effects]; 12. Testosterone [*blood]; | Provide MESH terms for the study
Effect of atorvastatin on testosterone levels | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticonvulsants [adverse effects, *therapeutic use]; 2. Epilepsy, Absence [*drug therapy, prevention & control]; 3. Ethosuximide [adverse effects, *therapeutic use]; 4. Lamotrigine [adverse effects, *therapeutic use]; 5. Randomized Controlled Trials as Topic; 6. Seizures [prevention & control]; 7. Treatment Failure; 8. Valproic Acid [adverse effects, *therapeutic use]; | Provide MESH terms for the study
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents | You are a research assistant. Based on the question please provide appropriate answers |
1. Amoxicillin [adverse effects, *therapeutic use]; 2. Anti-Bacterial Agents [adverse effects, *therapeutic use]; 3. Drug Administration Schedule; 4. Placebos [therapeutic use]; 5. Pneumonia [*drug therapy]; 6. Randomized Controlled Trials as Topic; 7. Recurrence; 8. *Respiratory Sounds; 9. Treatment Outcome; 10. World Health Organization; | Provide MESH terms for the study
Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO‐defined non‐severe pneumonia and wheeze | You are a research assistant. Based on the question please provide appropriate answers |
1. Anemia, Iron-Deficiency [complications, *therapy]; 2. Bias; 3. Colitis, Ulcerative [*complications]; 4. Crohn Disease [*complications]; 5. Disaccharides [administration & dosage, adverse effects]; 6. Erythropoietin [administration & dosage]; 7. Ferric Compounds [administration & dosage, adverse effects]; 8. Ferric Oxide, Saccharated [administration & dosage, adverse effects]; 9. Fumarates [administration & dosage, adverse effects]; 10. Hematinics [*administration & dosage, adverse effects]; 11. Iron Compounds [administration & dosage, adverse effects]; 12. Maltose [administration & dosage, adverse effects, analogs & derivatives]; 13. Placebos [administration & dosage]; 14. Pyrones [administration & dosage, adverse effects]; 15. Randomized Controlled Trials as Topic [statistics & numerical data]; | Provide MESH terms for the study
Interventions for treating iron deficiency anaemia in inflammatory bowel disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Bronchopulmonary Dysplasia [epidemiology]; 3. Cause of Death; 4. Cyclooxygenase Inhibitors [administration & dosage, adverse effects, *therapeutic use]; 5. Ductus Arteriosus, Patent [*drug therapy, mortality, surgery]; 6. Enterocolitis, Necrotizing [chemically induced]; 7. Gastrointestinal Hemorrhage [chemically induced]; 8. Incidence; 9. Indomethacin [administration & dosage, adverse effects, *therapeutic use]; 10. Infant, Low Birth Weight; 11. Infant, Premature; 12. Ligation [statistics & numerical data]; 13. Oxygen Inhalation Therapy [statistics & numerical data]; 14. Placebos [therapeutic use]; 15. Randomized Controlled Trials as Topic [statistics & numerical data]; | Provide MESH terms for the study
Indomethacin for symptomatic patent ductus arteriosus in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Body Weight; 2. Enteral Nutrition [adverse effects, *methods]; 3. Enterocolitis, Necrotizing [epidemiology, etiology]; 4. Fluid Therapy; 5. Infant Formula; 6. Infant, Premature [*growth & development]; 7. Infant, Very Low Birth Weight [*growth & development]; 8. Milk, Human; 9. Randomized Controlled Trials as Topic; 10. Weight Gain; | Provide MESH terms for the study
Early full enteral feeding for preterm or low birth weight infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Chlorhexidine [therapeutic use]; 2. *Critical Illness; 3. Incidence; 4. Intensive Care Units [statistics & numerical data]; 5. Length of Stay; 6. Mouthwashes [therapeutic use]; 7. Oral Hygiene [*methods]; 8. Pneumonia, Ventilator-Associated [epidemiology, mortality, *prevention & control]; 9. Randomized Controlled Trials as Topic; 10. Respiration, Artificial [*adverse effects, statistics & numerical data]; 11. Toothbrushing [instrumentation, methods]; | Provide MESH terms for the study
Oral hygiene care for critically ill patients to prevent ventilator‐associated pneumonia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Ambulatory Care; 2. Anticoagulants [adverse effects, *therapeutic use]; 3. Antineoplastic Agents [adverse effects]; 4. Antithrombins [therapeutic use]; 5. Bias; 6. Factor Xa Inhibitors [therapeutic use]; 7. Hemorrhage [chemically induced]; 8. Heparin [adverse effects, therapeutic use]; 9. Heparin, Low-Molecular-Weight [adverse effects, therapeutic use]; 10. Neoplasms [complications, *drug therapy]; 11. Primary Prevention [*methods]; 12. Pulmonary Embolism [etiology, prevention & control]; 13. Randomized Controlled Trials as Topic; 14. Venous Thromboembolism [etiology, *prevention & control]; 15. Warfarin [adverse effects, therapeutic use]; | Provide MESH terms for the study
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy | You are a research assistant. Based on the question please provide appropriate answers |
1. Breathing Exercises [*methods]; 2. Cystic Fibrosis [*therapy]; 3. Forced Expiratory Flow Rates; 4. Inhalation [*physiology]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; 7. Respiratory Muscles [*physiology]; 8. Vital Capacity; | Provide MESH terms for the study
Respiratory muscle training for cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Albuterol [therapeutic use]; 3. Bias; 4. Bronchiolitis [*drug therapy]; 5. Bronchodilator Agents [administration & dosage, *therapeutic use]; 6. Drug Therapy, Combination [methods]; 7. Epinephrine [therapeutic use]; 8. Length of Stay; 9. Magnesium Sulfate [administration & dosage, *therapeutic use]; 10. Patient Readmission [statistics & numerical data]; 11. Placebos [therapeutic use]; 12. Randomized Controlled Trials as Topic; 13. Saline Solution [therapeutic use]; 14. Severity of Illness Index; | Provide MESH terms for the study
Magnesium sulphate for treating acute bronchiolitis in children up to two years of age | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Body Height; 3. Confidence Intervals; 4. *Growth; 5. Growth Disorders [epidemiology]; 6. Hypercalcemia [etiology]; 7. Hypercalciuria [etiology]; 8. Micronutrients [administration & dosage]; 9. Placebos [administration & dosage]; 10. Randomized Controlled Trials as Topic; 11. Vitamin D [*administration & dosage, adverse effects]; 12. Vitamins [*administration & dosage, adverse effects]; | Provide MESH terms for the study
Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under five years of age | You are a research assistant. Based on the question please provide appropriate answers |
1. 25-Hydroxyvitamin D 2 [blood]; 2. Bone and Bones [*physiology]; 3. Bone Density; 4. *Breast Feeding; 5. Hypercalcemia [etiology]; 6. Lactation; 7. *Mothers; 8. Randomized Controlled Trials as Topic; 9. Rickets [blood]; 10. Term Birth; 11. Vitamin D [*administration & dosage, adverse effects]; 12. Vitamin D Deficiency [epidemiology, *prevention & control]; 13. Vitamins [*administration & dosage, adverse effects]; | Provide MESH terms for the study
Vitamin D supplementation for term breastfed infants to prevent vitamin D deficiency and improve bone health | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Inflammatory Agents, Non-Steroidal [adverse effects, *therapeutic use]; 2. Cause of Death; 3. Cerebral Intraventricular Hemorrhage [epidemiology]; 4. Chronic Disease; 5. Ductus Arteriosus, Patent [mortality, *therapy]; 6. Enterocolitis, Necrotizing [epidemiology]; 7. Hemodynamics; 8. Ibuprofen [adverse effects, therapeutic use]; 9. Indomethacin [adverse effects, therapeutic use]; 10. Infant, Premature; 11. Ligation [methods]; 12. Lung Diseases [epidemiology]; 13. Pneumothorax; 14. Randomized Controlled Trials as Topic; 15. Time Factors; 16. Time-to-Treatment; 17. *Watchful Waiting; | Provide MESH terms for the study
Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Acetylcysteine [adverse effects, *therapeutic use]; 2. Bias; 3. Cause of Death; 4. Hepatic Encephalopathy; 5. Liver Failure, Acute [*drug therapy, mortality, surgery]; 6. Liver Transplantation [statistics & numerical data]; 7. Placebos [therapeutic use]; 8. Prognosis; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
N‐acetylcysteine for non‐paracetamol (acetaminophen)‐related acute liver failure | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease [mortality, psychology, therapy]; 2. Anxiety [prevention & control]; 3. Communication; 4. Consumer Health Information [methods]; 5. Critical Illness [mortality, psychology, *therapy]; 6. Disease Progression; 7. *Emergency Treatment; 8. *Family; 9. Health Knowledge, Attitudes, Practice; 10. Negotiating [methods]; 11. *Patient Acceptance of Health Care; 12. Patient Education as Topic [methods]; 13. Patient Participation [*methods]; 14. *Patient Safety; 15. Randomized Controlled Trials as Topic; 16. Self Efficacy; 17. Symptom Assessment [methods]; | Provide MESH terms for the study
Interventions to increase patient and family involvement in escalation of care for acute life‐threatening illness in community health and hospital settings | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Bias; 3. Diarrhea [*therapy]; 4. Probiotics [*therapeutic use]; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Probiotics for treating acute infectious diarrhoea | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Age Factors; 3. Heptavalent Pneumococcal Conjugate Vaccine [adverse effects, therapeutic use]; 4. Otitis Media [microbiology, *prevention & control]; 5. Otitis Media with Effusion [drug therapy]; 6. *Pneumococcal Vaccines [adverse effects, therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Vaccines, Conjugate [adverse effects, therapeutic use]; | Provide MESH terms for the study
Pneumococcal conjugate vaccines for preventing acute otitis media in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Blood Urea Nitrogen; 3. Body Height; 4. Bone Diseases, Metabolic [epidemiology]; 5. Child Development [*physiology]; 6. Confidence Intervals; 7. Enteral Nutrition; 8. Enterocolitis, Necrotizing [epidemiology]; 9. *Food, Fortified; 10. Head [anatomy & histology, growth & development]; 11. *Infant Formula; 12. Infant Nutritional Physiological Phenomena; 13. Infant, Premature [*growth & development]; 14. Infant, Very Low Birth Weight [*growth & development]; 15. *Milk, Human; 16. Randomized Controlled Trials as Topic; 17. Retinopathy of Prematurity [epidemiology]; 18. Weight Gain; | Provide MESH terms for the study
Individualized versus standard diet fortification for growth and development in preterm infants receiving human milk | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Body Height; 3. Child Development [*physiology]; 4. Confidence Intervals; 5. Head [growth & development]; 6. Infant Formula [*chemistry]; 7. Infant Mortality; 8. Infant, Premature [blood, *growth & development]; 9. Intensive Care Units, Neonatal; 10. Length of Stay; 11. Milk Proteins [*administration & dosage]; 12. Milk, Human [*chemistry]; 13. Randomized Controlled Trials as Topic; 14. Weight Gain; | Provide MESH terms for the study
Comparison of different protein concentrations of human milk fortifier for promoting growth and neurological development in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Body Weight; 3. Cerebral Palsy [*rehabilitation]; 4. *Motor Activity; 5. Neurological Rehabilitation [methods]; 6. *Orthotic Devices; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Time Factors; 10. Walking [*education]; 11. Walking Speed; | Provide MESH terms for the study
Mechanically assisted walking training for walking, participation, and quality of life in children with cerebral palsy | You are a research assistant. Based on the question please provide appropriate answers |
1. Anxiety Disorders [*therapy]; 2. Bias; 3. *Cognitive Behavioral Therapy; 4. Confidence Intervals; 5. Depression [therapy]; 6. Lost to Follow-Up; 7. Parents; 8. Randomized Controlled Trials as Topic; 9. Remission Induction; 10. Time Factors; 11. *Waiting Lists; | Provide MESH terms for the study
Cognitive behavioural therapy for anxiety disorders in children and adolescents | You are a research assistant. Based on the question please provide appropriate answers |
1. Chronic Disease; 2. Esophageal and Gastric Varices [*complications]; 3. Gastrointestinal Hemorrhage [*prevention & control]; 4. Hypertension, Portal [*complications]; 5. Ligation [*methods]; 6. Liver Diseases [*complications]; 7. *Portal Vein; 8. Primary Prevention [methods]; 9. *Sclerotherapy; 10. Venous Thrombosis [*therapy]; | Provide MESH terms for the study
Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticonvulsants [adverse effects, *therapeutic use]; 2. Bias; 3. Drug Resistant Epilepsy [*drug therapy]; 4. Drug Therapy, Combination; 5. Randomized Controlled Trials as Topic; 6. Triazoles [adverse effects, *therapeutic use]; | Provide MESH terms for the study
Rufinamide add‐on therapy for drug‐resistant epilepsy | You are a research assistant. Based on the question please provide appropriate answers |
1. Landau-Kleffner Syndrome [*drug therapy]; 2. Sleep, Slow-Wave [*drug effects]; 3. Syndrome; | Provide MESH terms for the study
Pharmacological treatment for continuous spike‐wave during slow wave sleep syndrome and Landau‐Kleffner Syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Bicuspid; 3. Cariostatic Agents [*therapeutic use]; 4. Dental Caries [*prevention & control]; 5. Dentition, Permanent; 6. Fluorides, Topical [therapeutic use]; 7. Molar; 8. Pit and Fissure Sealants [*therapeutic use]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Pit and fissure sealants versus fluoride varnishes for preventing dental decay in the permanent teeth of children and adolescents | You are a research assistant. Based on the question please provide appropriate answers |
1. Apnea [therapy]; 2. Continuous Positive Airway Pressure; 3. Disorders of Excessive Somnolence [therapy]; 4. Exercise; 5. Isotonic Contraction; 6. Myofunctional Therapy [*methods]; 7. Oropharynx [physiology]; 8. Randomized Controlled Trials as Topic; 9. Sleep Apnea, Obstructive [*therapy]; 10. Snoring [therapy]; 11. Therapeutic Irrigation; 12. Waiting Lists; | Provide MESH terms for the study
Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Community Mental Health Services; 3. Early Medical Intervention [*methods]; 4. Hospitalization [statistics & numerical data]; 5. Psychotic Disorders [*therapy]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Specialised early intervention teams for recent‐onset psychosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Affective Disorders, Psychotic [*therapy]; 2. Bias; 3. Community Mental Health Services; 4. Confidence Intervals; 5. Early Medical Intervention [*methods]; 6. Randomized Controlled Trials as Topic; 7. Remission Induction [methods]; 8. Schizophrenia [*therapy]; 9. Time Factors; | Provide MESH terms for the study
Specialised early intervention teams (extended time) for recent‐onset psychosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. *Breathing Exercises; 3. Cardiorespiratory Fitness [*physiology]; 4. Exercise [*physiology]; 5. Heart Defects, Congenital [*rehabilitation]; 6. Muscle Strength; 7. Oxygen Consumption [physiology]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Physical activity interventions for people with congenital heart disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticonvulsants [*therapeutic use]; 2. Bias; 3. Cost-Benefit Analysis; 4. Epilepsy [*drug therapy, psychology]; 5. Medication Adherence [*psychology]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Self Efficacy; | Provide MESH terms for the study
Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Pain [diagnosis, *prevention & control]; 2. Attention; 3. Bias; 4. Pain Management [methods]; 5. Pain Measurement; 6. Pain Perception; 7. Pain, Procedural [diagnosis, *prevention & control]; 8. Randomized Controlled Trials as Topic; 9. *Virtual Reality; | Provide MESH terms for the study
Virtual reality distraction for acute pain in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Bias; 3. Blood Glucose [analysis]; 4. Carbamates [administration & dosage]; 5. Cystic Fibrosis [blood, *complications]; 6. Diabetes Mellitus [blood, *drug therapy, etiology]; 7. Fasting [blood]; 8. Hyperglycemia [drug therapy]; 9. Hypoglycemic Agents [*administration & dosage]; 10. Insulin [*administration & dosage]; 11. Insulin Glargine [administration & dosage]; 12. Insulin, Isophane [administration & dosage]; 13. Piperidines [administration & dosage]; 14. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Drug treatments for managing cystic fibrosis‐related diabetes | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Bronchopulmonary Dysplasia [epidemiology]; 3. Continuous Positive Airway Pressure [*methods]; 4. *Infant, Premature; 5. Intermittent Positive-Pressure Ventilation [statistics & numerical data]; 6. Pneumothorax [epidemiology]; 7. Randomized Controlled Trials as Topic; 8. Respiratory Distress Syndrome, Newborn [mortality, *therapy]; | Provide MESH terms for the study
Early versus delayed continuous positive airway pressure (CPAP) for respiratory distress in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Bronchopulmonary Dysplasia [etiology]; 2. Continuous Positive Airway Pressure [adverse effects, *methods]; 3. Infant, Low Birth Weight; 4. *Infant, Premature; 5. Intermittent Positive-Pressure Ventilation [adverse effects]; 6. Outcome Assessment, Health Care; 7. Pneumothorax [etiology]; 8. Pulmonary Surfactants [therapeutic use]; 9. Randomized Controlled Trials as Topic; 10. Respiratory Distress Syndrome, Newborn [mortality, *therapy]; 11. Respiratory Insufficiency [prevention & control]; 12. Selection Bias; 13. Treatment Failure; | Provide MESH terms for the study
Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Aerosols; 2. Air Filters; 3. *Air Microbiology; 4. Bacterial Infections [*prevention & control]; 5. Colony Count, Microbial [methods]; 6. Dentistry; 7. Disinfectants; 8. Infection Control, Dental [economics, instrumentation, *methods]; 9. Occupational Diseases [*prevention & control]; 10. Randomized Controlled Trials as Topic [statistics & numerical data]; 11. Rubber Dams; 12. Suction; 13. Virus Diseases [*prevention & control]; | Provide MESH terms for the study
Interventions to reduce contaminated aerosols produced during dental procedures for preventing infectious diseases | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [adverse effects, *therapeutic use]; 2. Bias; 3. Cardiac Surgical Procedures [*methods, mortality]; 4. Cardiopulmonary Bypass [*adverse effects, mortality]; 5. Cause of Death; 6. Dexamethasone [therapeutic use]; 7. Heart-Lung Machine [adverse effects]; 8. Hospital Mortality; 9. Hydrocortisone [therapeutic use]; 10. Inflammation [etiology, *prevention & control]; 11. Intensive Care Units, Pediatric [statistics & numerical data]; 12. Length of Stay; 13. Methylprednisolone [therapeutic use]; 14. Randomized Controlled Trials as Topic; 15. Respiration, Artificial [statistics & numerical data]; | Provide MESH terms for the study
Prophylactic corticosteroids for paediatric heart surgery with cardiopulmonary bypass | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Dust [analysis, *prevention & control]; 3. Environmental Exposure [*prevention & control]; 4. Environmental Restoration and Remediation [*methods]; 5. Floors and Floorcoverings; 6. Lead [blood]; 7. Lead Poisoning [*prevention & control]; 8. Paint [toxicity]; 9. Randomized Controlled Trials as Topic; 10. Secondary Prevention [*methods]; 11. Soil Pollutants; | Provide MESH terms for the study
Household interventions for secondary prevention of domestic lead exposure in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Amino Acids, Branched-Chain [*administration & dosage]; 2. Child Development [*drug effects]; 3. Infant, Newborn [*growth & development]; 4. Infant, Premature [growth & development]; | Provide MESH terms for the study
Branched‐chain amino acid supplementation for improving growth and development in term and preterm neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. Antioxidants [*therapeutic use]; 2. Asthma [drug therapy]; 3. Attention Deficit Disorder with Hyperactivity [drug therapy]; 4. Bias; 5. Bone Diseases, Metabolic [drug therapy]; 6. Brain Injuries, Traumatic [drug therapy]; 7. Cardiovascular Diseases [drug therapy]; 8. Chronic Disease [*drug therapy]; 9. Diabetes Mellitus, Type 1 [drug therapy]; 10. Diabetes Mellitus, Type 2 [drug therapy]; 11. Erectile Dysfunction [drug therapy]; 12. Flavonoids [*therapeutic use]; 13. Hypertension [drug therapy]; 14. Osteoarthritis [drug therapy]; 15. Pinus; 16. Plant Bark [*chemistry]; 17. Plant Extracts [*therapeutic use]; 18. Randomized Controlled Trials as Topic; 19. Sexual Dysfunctions, Psychological [drug therapy]; 20. Venous Insufficiency [drug therapy]; | Provide MESH terms for the study
Pine bark (Pinus spp.) extract for treating chronic disorders | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Body Height; 3. *Dietary Proteins; 4. *Dietary Supplements; 5. Enterocolitis, Necrotizing [epidemiology]; 6. Head [growth & development]; 7. *Infant Nutritional Physiological Phenomena; 8. Infant, Premature [*growth & development]; 9. Length of Stay [statistics & numerical data]; 10. *Milk, Human [chemistry]; 11. Randomized Controlled Trials as Topic; 12. Weight Gain; | Provide MESH terms for the study
Protein supplementation of human milk for promoting growth in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Infective Agents [*administration & dosage]; 2. Bias; 3. Blindness [prevention & control]; 4. Erythromycin [administration & dosage]; 5. Ophthalmia Neonatorum [*prevention & control]; 6. Povidone-Iodine [administration & dosage]; 7. Randomized Controlled Trials as Topic; 8. Silver Nitrate [administration & dosage]; 9. Tetracycline [administration & dosage]; 10. Trachoma [prevention & control]; 11. Vision Disorders [prevention & control]; | Provide MESH terms for the study
Interventions for preventing ophthalmia neonatorum | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [therapeutic use]; 2. Bias; 3. Chronic Disease; 4. Ciprofloxacin [therapeutic use]; 5. *Hygiene; 6. Otitis Media, Suppurative [*therapy]; 7. Randomized Controlled Trials as Topic; 8. Suction [methods]; 9. Time Factors; | Provide MESH terms for the study
Aural toilet (ear cleaning) for chronic suppurative otitis media | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Coronavirus Infections [epidemiology, mortality, prevention & control]; 3. COVID-19 [epidemiology, mortality, *prevention & control]; 4. Incidence; 5. *Models, Theoretical; 6. Observational Studies as Topic; 7. *Pandemics; 8. Physical Distancing; 9. *Public Health; 10. *Quarantine; 11. SARS-CoV-2 [pathogenicity]; 12. Schools; 13. Severe Acute Respiratory Syndrome [epidemiology, mortality, prevention & control]; 14. Travel; 15. World Health Organization; | Provide MESH terms for the study
Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review | You are a research assistant. Based on the question please provide appropriate answers |
1. Antibodies, Monoclonal [therapeutic use]; 2. Antibodies, Monoclonal, Humanized [therapeutic use]; 3. Dermatologic Agents [*therapeutic use]; 4. Eczema [*drug therapy]; 5. Immunosuppressive Agents [*therapeutic use]; 6. *Network Meta-Analysis; 7. Placebos [therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Treatment Outcome; 10. Ustekinumab [therapeutic use]; | Provide MESH terms for the study
Systemic treatments for eczema: a network meta‐analysis | You are a research assistant. Based on the question please provide appropriate answers |
1. Body Weight; 2. Dietary Carbohydrates [*administration & dosage]; 3. *Dietary Supplements; 4. Enterocolitis, Necrotizing [epidemiology]; 5. Food Intolerance [epidemiology]; 6. *Infant Nutritional Physiological Phenomena; 7. Infant, Premature [*growth & development]; 8. Length of Stay; 9. *Milk, Human [chemistry]; 10. Oligosaccharides [administration & dosage]; 11. *Prebiotics; | Provide MESH terms for the study
Carbohydrate supplementation of human milk to promote growth in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Age Factors; 2. Anxiety [diagnosis, epidemiology]; 3. Bias; 4. Depression [diagnosis, epidemiology]; 5. *Developing Countries [statistics & numerical data]; 6. Mental Disorders [etiology, *prevention & control]; 7. Patient Dropouts [statistics & numerical data]; 8. *Psychotherapy; 9. Randomized Controlled Trials as Topic; 10. Social Problems [*psychology]; 11. Stress Disorders, Post-Traumatic [diagnosis, epidemiology]; 12. *Stress, Physiological; 13. Stress, Psychological [*complications]; 14. Waiting Lists; | Provide MESH terms for the study
Psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Energy Metabolism; 3. Epilepsy [*psychology, *therapy]; 4. Fatigue [therapy]; 5. Psychotherapy; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Psychological treatments for people with epilepsy | You are a research assistant. Based on the question please provide appropriate answers |
1. alpha-Tocopherol [administration & dosage]; 2. Bias; 3. Cystic Fibrosis [*blood]; 4. *Dietary Supplements; 5. Exocrine Pancreatic Insufficiency [complications]; 6. Placebos [administration & dosage]; 7. Randomized Controlled Trials as Topic; 8. Vitamin E [*administration & dosage, blood, chemistry]; 9. Vitamin E Deficiency [prevention & control]; 10. Vitamins [*administration & dosage, chemistry]; | Provide MESH terms for the study
Vitamin E supplementation in people with cystic fibrosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Burns [pathology, *surgery]; 3. Debridement [*methods]; 4. Hydrotherapy [*methods]; 5. Operative Time; 6. Skin Transplantation; 7. Surgical Wound Infection [epidemiology, etiology]; 8. Therapeutic Irrigation [methods]; 9. Time Factors; 10. Wound Healing; | Provide MESH terms for the study
Hydrosurgical debridement versus conventional surgical debridement for acute partial‐thickness burns | You are a research assistant. Based on the question please provide appropriate answers |
1. Allopurinol [*therapeutic use]; 2. Blood Pressure [drug effects]; 3. Hypertension [complications, *drug therapy]; 4. Hyperuricemia [complications, *drug therapy]; 5. Patient Dropouts [statistics & numerical data]; 6. Placebos [therapeutic use]; 7. Prehypertension [drug therapy]; 8. Randomized Controlled Trials as Topic; 9. Uricosuric Agents [*therapeutic use]; | Provide MESH terms for the study
Pharmacotherapy for hyperuricaemia in hypertensive patients | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Aminosalicylic Acids [*administration & dosage]; 3. Anti-Inflammatory Agents, Non-Steroidal [*administration & dosage, adverse effects]; 4. Bias; 5. Colitis, Ulcerative [*drug therapy, prevention & control]; 6. Drug Administration Schedule; 7. Maintenance Chemotherapy [*methods]; 8. Medication Adherence [statistics & numerical data]; 9. Mesalamine [*administration & dosage]; 10. Patient Dropouts [statistics & numerical data]; 11. Placebos [therapeutic use]; 12. Randomized Controlled Trials as Topic; 13. Recurrence; 14. Remission Induction [methods]; 15. Sulfasalazine [administration & dosage, adverse effects]; | Provide MESH terms for the study
Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Glaucoma [*congenital, drug therapy, *surgery]; 2. Glaucoma Drainage Implants [adverse effects]; 3. Hyphema [etiology]; 4. Intraocular Pressure; 5. Mitomycin [therapeutic use]; 6. Postoperative Complications; 7. Randomized Controlled Trials as Topic; 8. Sclera [surgery]; 9. Trabecular Meshwork [surgery]; 10. Trabeculectomy [adverse effects, methods]; 11. Treatment Outcome; | Provide MESH terms for the study
Surgical interventions for primary congenital glaucoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Antiprotozoal Agents [administration & dosage, adverse effects]; 3. Azithromycin [administration & dosage, adverse effects]; 4. BCG Vaccine [therapeutic use]; 5. Hyperthermia, Induced; 6. Immunocompetence; 7. Injections, Intramuscular; 8. Injections, Intravenous; 9. Interferon-gamma [therapeutic use]; 10. Leishmaniasis Vaccines [therapeutic use]; 11. Leishmaniasis, Cutaneous [*therapy]; 12. Leishmaniasis, Mucocutaneous [therapy]; 13. Meglumine Antimoniate [administration & dosage, adverse effects]; 14. Pentoxifylline [administration & dosage, adverse effects]; 15. Phosphorylcholine [administration & dosage, adverse effects, analogs & derivatives]; 16. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Interventions for American cutaneous and mucocutaneous leishmaniasis | You are a research assistant. Based on the question please provide appropriate answers |
1. Dietary Fats [*administration & dosage]; 2. *Dietary Supplements; 3. *Infant Nutritional Physiological Phenomena; 4. Infant, Premature [*growth & development]; 5. *Milk, Human; | Provide MESH terms for the study
Fat supplementation of human milk for promoting growth in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Aminoglycosides [adverse effects, therapeutic use]; 2. Anti-Bacterial Agents [adverse effects, *therapeutic use]; 3. Azithromycin [adverse effects, therapeutic use]; 4. Cephalosporins [adverse effects, therapeutic use]; 5. Clindamycin [adverse effects, therapeutic use]; 6. Doxycycline [adverse effects, therapeutic use]; 7. Drug Therapy, Combination; 8. Nitroimidazoles [adverse effects, therapeutic use]; 9. Pelvic Inflammatory Disease [*drug therapy, microbiology]; 10. Publication Bias; 11. Quinolones [adverse effects, therapeutic use]; 12. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Antibiotic therapy for pelvic inflammatory disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Inflammatory Agents [therapeutic use]; 2. Fetal Blood [cytology]; 3. Hydrocortisone [therapeutic use]; 4. Hypothermia, Induced; 5. Hypoxia-Ischemia, Brain [complications, mortality, *therapy]; 6. *Stem Cell Transplantation; | Provide MESH terms for the study
Stem cell‐based interventions for the prevention of morbidity and mortality following hypoxic‐ischaemic encephalopathy in newborn infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Bias; 3. Immunoglobulins, Intravenous [*therapeutic use]; 4. Myocarditis [mortality, *therapy, virology]; 5. Progression-Free Survival; 6. Randomized Controlled Trials as Topic; 7. Stroke Volume [drug effects]; 8. Virus Diseases [mortality, *therapy]; | Provide MESH terms for the study
Intravenous immunoglobulin for presumed viral myocarditis in children and adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Antimalarials [administration & dosage, adverse effects, *therapeutic use]; 2. Drug Administration Schedule; 3. Glucosephosphate Dehydrogenase; 4. Malaria, Vivax [*drug therapy, enzymology]; 5. Primaquine [administration & dosage, adverse effects, *therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Recurrence; 8. Secondary Prevention; | Provide MESH terms for the study
Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax | You are a research assistant. Based on the question please provide appropriate answers |
1. Botswana [epidemiology]; 2. Cohort Studies; 3. Contact Tracing [instrumentation, *methods]; 4. Coronavirus Infections [epidemiology]; 5. COVID-19 [epidemiology, prevention & control]; 6. Disease Outbreaks [*prevention & control]; 7. Hemorrhagic Fever, Ebola [epidemiology, prevention & control]; 8. Mobile Applications [*statistics & numerical data]; 9. Models, Theoretical; 10. Patient Isolation [statistics & numerical data]; 11. Privacy; 12. Quarantine [statistics & numerical data]; 13. Secondary Prevention [methods, statistics & numerical data]; 14. Sierra Leone [epidemiology]; 15. Tuberculosis [epidemiology, prevention & control]; 16. United States [epidemiology]; 17. Whooping Cough [epidemiology, prevention & control]; | Provide MESH terms for the study
Digital contact tracing technologies in epidemics: a rapid review | You are a research assistant. Based on the question please provide appropriate answers |
1. Automobile Driving [*education]; 2. Bias; 3. Controlled Before-After Studies; 4. Intention; 5. Licensure [statistics & numerical data]; 6. Randomized Controlled Trials as Topic; 7. *Transportation; | Provide MESH terms for the study
Mobility management to prevent, reduce, or delay driving a car in teenagers | You are a research assistant. Based on the question please provide appropriate answers |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.